CATEGORIES

27.04.2017

27.04.2017 08:42

Crowdfunding-Kampagne für Online-Magazin schlägt Rekorde

Bisher stammten die erfolgreichsten Schweizer Crowdfunding-Kampagnen von Startups mit Consumer-Products wie Uhren oder intelligenten Fernbedienungen, die ein internationales Publikum auf sich aufmerksam machen konnten. Nun hat mit der „Republik“ ein Deutschschweizer Online-Magazin den Kontrapunkt gesetzt: innerhalb weniger Stunden knackte es die Millionengrenze.

26.04.2017

26.04.2017 08:15

Parquery announces first close of seed financing

Parquery, an ETH Zurich spinoff, announces the first close of its seed financing round. The new shareholders are experienced industrial angel investors and a strategic investor.

25.04.2017

25.04.2017 08:17

Bill & Melinda Gates foundation supports iM4TB

The Bill & Melinda Gates foundation has awarded EPFL-based foundation iM4TB $2.45 million to take their innovative anti-tuberculosis drug PBTZ169 into clinical trials.

19.04.2017

19.04.2017 17:00

Elektro-Skateboard ein Überflieger auf Kickstarter

Vor genau sechs Tagen lancierte SoFlow auf Kickstarter eine Crowdfunding Kampagne für sein E-Skatebord LouBoard. Das Finanzierungsziel: 80'000 Franken. Stand heute sind schon mehr als 90'000 Schweizer Franken zugesagt.

15.04.2017

15.04.2017 08:13

Airbus Venture, Partech Venture & Serena Capital invest in BestMile

BestMile’s seed round reaches $5.5M with the addition of $2M from Partech Ventures, Serena Capital and Airbus Ventures. In addition BestMile announced the appointment of a new Chief Technology Officer.

13.04.2017

13.04.2017 18:06

De‘ Longhi takes a 40% stake in Eversys

The De’ Longhi Group reached an agreement for the acquisition of the 40% of Swiss Group Eversys, with the option to acquire the remaining 60%. This agreement marks the entry of the De’ Longhi Group in the professional espresso coffee machine market, with a focus on the fully automatic models. The initial maximum cash out will amount to ca. CHF 21 million.

13.04.2017 14:45

Polyphor raises CHF 40 million in financing round

Polyphor Ltd., a clinical stage pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases, today announced that it completed a CHF 40 million private placement. Exisiting Polyphor investors contributed to 98% of the financing.

Show All

Events

04.05.2017 09:00 - 17:00

Swiss Biotech Day 2017 Congress Center Basel, Switzerland

MEET US

Show All

Trainings

02.05.2017 16:11 - 16:17

Exit Strategy for Startup EPFL Innovation Park

Top viewed

Show All

Video

Tweets

Principal

Award alarm

Do not miss any deadline and stay informed about all the important awards with our awards list. You can also follow all or your favourite awards after logging in. You will receive a weekly tailor-made award alert newsletter whenever there is news about your selected awards.

Partners

Contributors